|
|
|
Insider
Information: |
Bjerkholt Eric |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
574,968 |
|
Indirect Shares
|
83,827 |
|
|
Direct
Value |
$683,647 |
|
|
Indirect Value
|
$51,637 |
|
|
Total
Shares |
658,795 |
|
|
Total
Value |
$735,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
6
|
4
|
Stock
price went up :
|
6
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
6.0
|
4.0
|
Percentage
Gain/Loss : |
47.4%
|
276.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Viracta Therapeutics Ord Shs |
VIRX |
EVP, CFO & Corp. Secre... |
2016-02-29 |
100,922 |
2016-02-29 |
83,827 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Microbot Medical Inc |
MBOT |
Director |
2016-01-01 |
273,759 |
2010-03-01 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Corium International, Inc. |
CORI |
Director |
2016-05-18 |
0 |
2018-11-27 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Aimmune Therapeutics, Inc. |
AIMT |
Chief Financial Officer |
2020-10-13 |
0 |
2017-05-12 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Cerus Corp |
CERS |
Director |
2024-06-05 |
182,133 |
2019-10-04 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Chinook Therapeutics Inc |
KDNY |
Chief Financial Officer |
2023-08-11 |
0 |
|
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Calcimedica Ord Shs |
CALC |
Director |
2023-05-31 |
3,684 |
2023-03-23 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Mirum Pharmaceuticals, Inc. |
MIRM |
|
2024-05-10 |
14,470 |
2023-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
|
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(39,371) |
0 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2023-09-11 |
4 |
B |
$29.65 |
$296,492 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
CHIEF FINANCIAL OFFICER |
|
2024-03-18 |
4 |
B |
$25.80 |
$51,600 |
D/D |
2,000 |
12,000 |
0.01 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
CHIEF FINANCIAL OFFICER |
|
2024-03-27 |
4 |
B |
$24.80 |
$49,600 |
D/D |
2,000 |
14,000 |
0.01 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
CHIEF FINANCIAL OFFICER |
|
2024-05-10 |
4 |
A |
$21.05 |
$9,892 |
D/D |
470 |
14,470 |
0 |
- |
|
KDNY |
Chinook Therapeutics Inc |
Chief Financial OfficerOfficer |
|
2020-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
% |
|
MBOT |
Microbot Medical Inc |
Director |
|
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
MBOT |
Microbot Medical Inc |
Director |
|
2011-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
MBOT |
Microbot Medical Inc |
Director |
|
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,000 |
0 |
- |
|
MBOT |
Microbot Medical Inc |
Director |
|
2012-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
12,000 |
0 |
- |
|
MBOT |
Microbot Medical Inc |
Director |
|
2013-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
22,000 |
0 |
- |
|
MBOT |
Microbot Medical Inc |
Director |
|
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
47,164 |
69,164 |
0 |
- |
|
MBOT |
Microbot Medical Inc |
Director |
|
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
58,253 |
127,417 |
0 |
- |
|
MBOT |
Microbot Medical Inc |
Director |
|
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
146,342 |
273,759 |
0 |
- |
|
CORI |
Corium International, Inc... |
Director |
|
2016-05-18 |
4 |
B |
$3.54 |
$36,867 |
I/I |
10,369 |
5,659 |
2.1 |
- |
|
CORI |
Corium International, Inc... |
Director |
|
2016-05-19 |
4 |
B |
$3.70 |
$52,333 |
I/I |
14,131 |
12,000 |
2.1 |
- |
|
CORI |
Corium International, Inc... |
Director |
|
2018-11-27 |
4 |
D |
$12.50 |
$306,250 |
I/I |
(24,500) |
0 |
0 |
- |
|
CERS |
Cerus Corp |
Director |
|
2019-10-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,282 |
4,282 |
0 |
- |
|
CERS |
Cerus Corp |
Director |
|
2020-01-29 |
4 |
B |
$4.15 |
$83,000 |
D/D |
20,000 |
24,282 |
2.39 |
% |
|
CERS |
Cerus Corp |
Director |
|
2020-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,281 |
28,563 |
0 |
- |
|
CERS |
Cerus Corp |
Director |
|
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,228 |
41,791 |
0 |
- |
|
CERS |
Cerus Corp |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,888 |
56,679 |
0 |
- |
|
CERS |
Cerus Corp |
Director |
|
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,454 |
77,133 |
0 |
- |
|
CALC |
Calcimedica Ord Shs |
Director |
|
2023-03-23 |
4 |
|
$0.00 |
$0 |
D/D |
1,429 |
1,429 |
0 |
- |
|
CALC |
Calcimedica Ord Shs |
Director |
|
2023-05-16 |
4 |
B |
$2.70 |
$2,160 |
D/D |
800 |
2,229 |
2.31 |
- |
|
83 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|